Ch. 461WPG0460: Want to make original research drugs? A compromise that benefits both sides! Black-hearted capitalist! Harvesting multiple times?
Key Plot Points and Events
- Wugengtian Pharmaceutical Group acquires the Rheumatology Project led by Professor Xiong Yuanji, following the model of the Lupus Project led by Professor Wei Zhenghong.
- The Lupus Relief Agent, developed by Professor Wei's team, successfully passes the first phase of clinical trials.
- An Wuyang proposes a compromise: develop the Lupus Relief Agent as both an innovative drug (for global markets) and a botanical medicine (to bypass clinical trials and enter the domestic market quickly).
- An Wuyang invites shareholders to discuss pricing and sales territories for the Lupus Relief Agent.
Character Developments
- Professor Wei Zhenghong shows willingness to compromise and adapt her innovative drug plans to accommodate investors' views.
- An Wuyang demonstrates strategic thinking and compromise, aiming to balance the interests of investors, researchers, and patients.
- Chen Hongzhi and Li Shiyu exhibit capitalist tendencies, prioritizing long-term profits over the medicine's effectiveness.
- Yang Yuxin considers a membership repurchase system to cater to patients with relapsing conditions.
Significant Themes
- Balancing innovation and profit: An Wuyang navigates the tension between Professor Wei's desire for an innovative drug and investors' focus on short-term gains.
- The role of capitalism in healthcare: Chen Hongzhi and Li Shiyu prioritize long-term profits over patients' well-being, highlighting the potential conflicts of interest in pharmaceutical development.
- The impact of lifestyle on health: The Lupus Relief Agent's effectiveness is influenced by patients' habits, raising questions about personal responsibility and the limits of medicine.
Character Interactions
- An Wuyang collaborates with Professor Wei Zhenghong, showing respect for her work while guiding her towards a compromise solution.
- Shareholders discuss pricing and sales strategies for the Lupus Relief Agent, revealing their priorities and business acumen.
- Yang Yuxin considers a membership repurchase system, demonstrating empathy for patients with relapsing conditions and a willingness to adapt sales strategies to meet their needs.